Supplementary Table S3 from Cadonilimab Combined with Chemotherapy with or Without Bevacizumab As First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study

Hanmei Lou,Hongbing Cai,Xin Huang,Guiling Li,Li Wang,Fei Liu,Wenjing Qin,Ting Liu,Wei Liu,Zhongmin Maxwell Wang,Baiyong Li,Yu Xia,Jing Wang

crossref（2024）

引用 0|浏览4

暂无评分

摘要

Supplementary Table S3. Representativeness of Study Participants.

更多

查看译文

关键词

Cancer Progression

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要